This leads to a rapid increase in the expression of CCR5 on myeloid cells at the BM to a rapid mobilization of CD11b+Ly6GhighLy6Clow myeloid cells that become PMN-MDSC at the tumor site (16). The gene discussed is CCR5; the disease is neoplasm.